Lv3
330 积分 2026-02-28 加入
利拉鲁肽对成年肥胖2型糖尿病患者身体成分和肌力的影响
14小时前
已完结
Petrelintide, a human amylin analogue for the treatment of obesity (ZUPREME 1): a randomised, double-blind, placebo-controlled, phase 2 trial
1天前
已完结
Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial
1天前
已完结
Beinaglutide for weight management in Chinese individuals with overweight or obesity: A phase 3 randomized controlled clinical study
1天前
已完结
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
1天前
已完结
Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation
3天前
已完结
Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial
15天前
已完结
Tirzepatide for Weight Reduction in Chinese Adults With Obesity
15天前
已完结
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity
15天前
已完结
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes
15天前
已完结
皖公网安备34019202002308
